← Back to Search
Malignant Mesothelioma As An Oxidative Stress-induced Cancer: An Update.
S. H. Chew, S. Toyokuni
Published 2015 · Biology, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Malignant mesothelioma (MM) is a relatively rare cancer that occurs almost exclusively following respiratory exposure to asbestos in humans. Its pathogenesis is closely associated with iron overload and oxidative stress in mesothelial cells. On fiber exposure, mesothelial cells accumulate fibers simultaneously with iron, which either performs physical scissor function or catalyzes free radical generation, leading to oxidative DNA damage such as strand breaks and base modifications, followed by activation of intracellular signaling pathways. Chrysotile, per se without iron, causes massive hemolysis and further adsorbs hemoglobin. Exposure to indigestible foreign materials also induces chronic inflammation, involving consistent generation of free radicals and subsequent activation of NALP3 inflammasomes in macrophages. All of these contribute to mesothelial carcinogenesis. Genomic alterations most frequently involve homozygous deletion of INK4A/4B, and other pathways such as Hippo and TGF-β pathways are also affected in MM. Recently, analyses of familial MM sorted out BAP1 as a novel responsible tumor suppressor gene, whose function is not fully elucidated. Five-year survival of mesothelioma is still ~8%, and this cancer is increasing worldwide. Connective tissue growth factor, a secretory protein creating a vicious cycle mediated by β-catenin, has been recognized as a hopeful target for therapy, especially in sarcomatoid subtype. Recent research outcomes related to microRNAs and cancer stem cells also offer additional novel targets for the treatment of MM. Iron reduction as chemoprevention of mesothelioma is helpful at least in an animal preclinical study. Integrated approaches to fiber-induced oxidative stress would be necessary to overcome this currently fatal disease.
This paper references
Malignant pleural mesothelioma: update on treatment options with a focus on novel therapies.
A. Haas (2013)
Oncofetal Protein IMP3, a New Diagnostic Biomarker to Distinguish Malignant Mesothelioma From Reactive Mesothelial Proliferation
M. Shi (2011)
Carcinogenicity of fluoro-edenite, silicon carbide fibres and whiskers, and carbon nanotubes.
Y. Grosse (2014)
Treatment of wistar rats with a renal carcinogen, ferric nitrilotriacetate, causes dna‐protein cross‐linking between thymine and tyrosine in their renal chromatin
S. Toyokuni (1995)
Characterization of cancer stem cell properties of CD24 and CD26-positive human malignant mesothelioma cells.
H. Yamazaki (2012)
Negative modulation of mitochondrial oxidative phosphorylation by epigallocatechin-3 gallate leads to growth arrest and apoptosis in human malignant pleural mesothelioma cells.
D. Valenti (2013)
Metamorphosis of mesothelial cells with active horizontal motility in tissue culture
H. Nagai (2013)
Experimental asbestos carcinogenesis
A. L. Reeves (1971)
Peroxiredoxin 3 levels regulate a mitochondrial redox setpoint in malignant mesothelioma cells
B. Cunniff (2014)
Mesothelial cells: Their structure, function and role in serosal repair
S. Mutsaers (2002)
Induction of nuclear translocation of NF‐κB in epithelial cells by respirable mineral fibres
D. Brown (1999)
Soluble markers for diagnosis of malignant pleural mesothelioma.
A. Cristaudo (2011)
Chrysotile asbestos is the main cause of pleural mesothelioma.
A. Smith (1996)
Concentration of hyaluronic acid in pleural fluid as a diagnostic aid for malignant mesothelioma.
T. Pettersson (1988)
DNA base modifications in renal chromatin of wistar rats treated with a renal carcinogen, ferric nitrilotriacetate
S. Toyokuni (1994)
Translocation pathways for inhaled asbestos fibers
Giuseppe Miserocchi (2008)
Multimodal management of malignant pleural mesothelioma: where are we today?
P. V. Van Schil (2014)
Expression and activity of urokinase and its receptor in endothelial and pulmonary epithelial cells exposed to asbestos.
A. Barchowsky (1998)
The essential role of the mitochondria and reactive oxygen species in Cisplatin-mediated enhancement of fas ligand-induced apoptosis in malignant pleural mesothelioma.
J. Stewart (2007)
Mesothelial healing: Morphological and kinetic investigations
D. Whitaker (1985)
The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions
P. Illei (2003)
Germline BAP1 mutations predispose to malignant mesothelioma
J. Testa (2011)
The RASSF1A tumor suppressor
H. Donninger (2007)
MESOTHELIOMA IN A BRAKE REPAIR WORKER
A. Langer (1982)
CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth.
Takatsugu Ishimoto (2011)
Iron overload signature in chrysotile‐induced malignant mesothelioma
L. Jiang (2012)
Comparison of the Diagnostic Accuracy of the MSLN Gene Products, Mesothelin and Megakaryocyte Potentiating Factor, as Biomarkers for Mesothelioma in Pleural Effusions and Serum
J. Creaney (2013)
Aberrant methylation profile of human malignant mesotheliomas and its relationship to SV40 infection
M. Suzuki (2005)
The Therapeutic Potential of Modifying Inflammasomes and NOD-Like Receptors
F. Virgilio (2013)
Deferasirox Induces Mesenchymal–Epithelial Transition in Crocidolite-Induced Mesothelial Carcinogenesis in Rats
H. Nagai (2013)
Toward an improved definition of the tumor spectrum associated with BAP1 germline mutations.
T. Wiesner (2012)
Effectiveness of mesothelin family proteins and osteopontin for malignant mesothelioma
I. Pantazopoulos (2012)
Epidemiology of malignant mesothelioma--an outline.
J. C. Mcdonald (2010)
Utility of Osteopontin and Serum Mesothelin in Malignant Pleural Mesothelioma Diagnosis and Prognosis Assessment
B. Grigoriu (2007)
Oxidative stress-mediated HMGB1 biology
Y. Yu (2015)
Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis.
Kevin Hollevoet (2012)
Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma.
S. Jube (2012)
YAP1 is involved in mesothelioma development and negatively regulated by Merlin through phosphorylation.
T. Yokoyama (2008)
Hydrogen peroxide promotes epithelial to mesenchymal transition and stemness in human malignant mesothelioma cells.
Myung-Chul Kim (2013)
Hemolysis by asbestos.
J. Harington (1971)
Mesothelial regeneration in the rat and effect of urokinase.
S. Teranishi (1977)
Homozygous deletion of CDKN2A/2B is a hallmark of iron-induced high-grade rat mesothelioma
Q. Hu (2010)
Asbestos surface provides a niche for oxidative modification
H. Nagai (2011)
Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008.
V. Delgermaa (2011)
Genomic profiling of malignant pleural mesothelioma with array‐based comparative genomic hybridization shows frequent non‐random chromosomal alteration regions including JUN amplification on 1p32
T. Taniguchi (2007)
Patterns of 8-hydroxydeoxyguanosine formation in DNA and indications of oxidative stress in rat and human pleural mesothelial cells after exposure to crocidolite asbestos.
H. Fung (1997)
Malignant pleural mesothelioma: an update on biomarkers and treatment.
M. Ray (2009)
Role of Transcription Factor NF-κB in Asbestos-Induced TNFα Response from Macrophages☆
N. Cheng (1999)
Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma
C. Tabata (2012)
Interleukin-1β and tumour necrosis factor-α promote the transformation of human immortalised mesothelial cells by erionite
Y. Wang (2004)
Mesothelial regeneration is not dependent on subserosal cells
S. Mutsaers (2000)
Peroxiredoxin 3 Is a Redox-Dependent Target of Thiostrepton in Malignant Mesothelioma Cells
Kheng Newick (2012)
EGFR overexpression in malignant pleural mesothelioma. An immunohistochemical and molecular study with clinico-pathological correlations.
A. Destro (2006)
Pro-tumorigenic Effects of miR-31 Loss in Mesothelioma*
S. Ivanov (2010)
The role of free radicals in asbestos-induced diseases.
D. Kamp (1992)
p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma.
J. Cheng (1994)
Mechanisms of Epithelial-Mesenchymal Transition of Peritoneal Mesothelial Cells During Peritoneal Dialysis
H. Lee (2007)
Induction of metaphase and anaphase/telophase abnormalities by asbestos fibers in rat pleural mesothelial cells in vitro.
M. Yegles (1993)
Role of reactive oxygen metabolites in crocidolite asbestos toxicity to mouse macrophages.
L. Goodglick (1986)
MicroRNAs Dysregulation in Human Malignant Pleural Mesothelioma
Veronica Balatti (2011)
THE FIRST FIFTY YEARS.
Dall Jl (1963)
Megakaryocyte potentiating factor as a tumor marker of malignant pleural mesothelioma: evaluation in comparison with mesothelin.
K. Iwahori (2008)
Mitochondrial‐targeted nitroxides disrupt mitochondrial architecture and inhibit expression of peroxiredoxin 3 and FOXM1 in malignant mesothelioma cells
B. Cunniff (2013)
Combined CA125 and mesothelin levels for the diagnosis of malignant mesothelioma.
J. Creaney (2007)
A Functional Interaction between Hippo-YAP Signaling and FoxO1 Mediates the Oxidative Stress Response
Dan Shao (2014)
Asbestos-induced phosphorylation of epidermal growth factor receptor is linked to c-fos and apoptosis.
C. Zanella (1999)
Haemolytic Activity of Asbestos and other Mineral Dusts
G. Macnab (1967)
DNA breakage in asbestos-treated normal and transformed (TSV40) rat pleural mesothelial cells.
V. Levresse (2000)
[Mechanisms of asbestos-induced carcinogenesis].
S. Toyokuni (2011)
Iron-mediated DNA damage: sensitive detection of DNA strand breakage catalyzed by iron.
S. Toyokuni (1992)
A mouse model recapitulating molecular features of human mesothelioma.
D. Altomare (2005)
Mesotheliomata in Rats after Inoculation with Asbestos and Other Materials
J. Wagner (1973)
Diagnostic values of soluble mesothelin-related peptides for malignant pleural mesothelioma: updated meta-analysis
Ai Cui (2014)
Plasma versus serum levels of osteopontin and mesothelin in patients with malignant mesothelioma--which is best?
J. Creaney (2011)
Role of macrophages in mesothelial healing
Z. Fotev (1987)
High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas.
A. Bianchi (1995)
Diagnostic performance of soluble mesothelin and megakaryocyte potentiating factor in mesothelioma.
K. Hollevoet (2010)
Characteristics and modifying factors of asbestos‐induced oxidative DNA damage
L. Jiang (2008)
Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma.
H. Pass (2012)
DNA single- and double-strand breaks produced by ferric nitrilotriacetate in relation to renal tubular carcinogenesis.
S. Toyokuni (1993)
Diffuse Pleural Mesothelioma and Asbestos Exposure in the North Western Cape Province
J. Wagner (1960)
Asbestos: scientific developments and implications for public policy.
B. Mossman (1990)
Continuous exposure to chrysotile asbestos can cause transformation of human mesothelial cells via HMGB1 and TNF-α signaling.
Fang Wei Qi (2013)
Combined serum mesothelin and carcinoembryonic antigen measurement in the diagnosis of malignant mesothelioma.
K. Fukuoka (2013)
Syntenic relationships between genomic profiles of fiber-induced murine and human malignant mesothelioma.
D. Jean (2011)
Diameter and rigidity of multiwalled carbon nanotubes are critical factors in mesothelial injury and carcinogenesis
H. Nagai (2011)
Association of MiR-126 with Soluble Mesothelin-Related Peptides, a Marker for Malignant Mesothelioma
L. Santarelli (2011)
Serum Thioredoxin-1 as a Diagnostic Marker for Malignant Peritoneal Mesothelioma
C. Tabata (2013)
MicroRNA-126 suppresses mesothelioma malignancy by targeting IRS1 and interfering with the mitochondrial function.
M. Tomasetti (2014)
Immunocytochemistry of CD146 is useful to discriminate between malignant pleural mesothelioma and reactive mesothelium
A. Sato (2010)
Role of extracellular signal-regulated protein kinases in apoptosis by asbestos and H2O2.
L. A. Jiménez (1997)
Effects of crocidolite and chrysotile asbestos on cellular uptake and metabolism of benzo(a)pyrene in hamster tracheal epithelial cells.
B. Mossman (1983)
Potential role of ferritin heavy chain in oxidative stress and apoptosis in human mesothelial and mesothelioma cells: implications for asbestos-induced oncogenesis.
W. Aung (2007)
Association between 8-hydroxy-2'-deoxyguanosine formation and DNA strand breaks mediated by copper and iron.
S. Toyokuni (1996)
Cigarette smoke increases the penetration of asbestos fibers into airway walls.
D. McFadden (1986)
Curcumin: A Double Hit on Malignant Mesothelioma
Jill M. Miller (2014)
Contrasting genome-wide distribution of 8-hydroxyguanine and acrolein-modified adenine during oxidative stress-induced renal carcinogenesis.
S. Akatsuka (2006)
Identification of miRNA-103 in the Cellular Fraction of Human Peripheral Blood as a Potential Biomarker for Malignant Mesothelioma – A Pilot Study
D. Weber (2012)
Genome-wide Profiling of 8-Oxoguanine Reveals Its Association with Spatial Positioning in Nucleus
M. Yoshihara (2014)
Comparison of Osteopontin, Megakaryocyte Potentiating Factor, and Mesothelin Proteins as Markers in the Serum of Patients with Malignant Mesothelioma
J. Creaney (2008)
Intracellular protein binding to asbestos induces aneuploidy in human lung fibroblasts.
R. A. MacCorkle (2006)
A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma.
H. Benjamin (2010)
Asbestos fibre content of lungs with mesotheliomas in Osaka, Japan: a preliminary report.
K. Morinaga (1989)
Putative cancer stem cells in malignant pleural mesothelioma show resistance to cisplatin and pemetrexed.
L. Cortes-Dericks (2010)
Iron-induced carcinogenesis: the role of redox regulation.
S. Toyokuni (1996)
Magic but treatable? Tumours due to loss of merlin.
C. O. Hanemann (2008)
Markers for the non-invasive diagnosis of mesothelioma: a systematic review
S. van der Bij (2011)
TNF-α inhibits asbestos-induced cytotoxicity via a NF-κB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis
H. Yang (2006)
Combination of MiR-103a-3p and Mesothelin Improves the Biomarker Performance of Malignant Mesothelioma Diagnosis
D. Weber (2014)
Non-asbestos related diffuse malignant mesothelioma.
M. Huncharek (2002)
Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma
G. V. Gee (2010)
RAT MODEL DEMONSTRATES A HIGH RISK OF TREMOLITE BUT A LOW RISK OF ANTHOPHYLLITE FOR MESOTHELIAL CARCINOGENESIS
Dilinuer Aierken (2014)
Long crocidolite asbestos fibers cause polyploidy by sterically blocking cytokinesis.
C. Jensen (1996)
Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Catherine Dostert (2008)
Fenton Reaction Induced Cancer in Wild Type Rats Recapitulates Genomic Alterations Observed in Human Cancer
S. Akatsuka (2012)
Black spots concentrate oncogenic asbestos fibers in the parietal pleura. Thoracoscopic and mineralogic study.
C. Boutin (1996)
Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma
K. Donaldson (2009)
Role of iron in carcinogenesis: Cancer as a ferrotoxic disease
S. Toyokuni (2009)
Pleural mesothelioma side populations have a precursor phenotype.
C. Frei (2011)
Induction of mesothelioma in p53+/- mouse by intraperitoneal application of multi-wall carbon nanotube.
A. Takagi (2008)
Regeneration of parietal and visceral peritoneum: an electron microscopical study.
Raftery At (1973)
Mitochondrial targeting of α-tocopheryl succinate enhances its anti-mesothelioma efficacy
J. Kovářová (2014)
High-mobility group box 1, oxidative stress, and disease.
D. Tang (2011)
Mesothelioma from chrysotile asbestos: update.
M. Kanarek (2011)
Correlation between fibre content of the lung and disease in east London asbestos factory workers.
J. Wagner (1988)
Sialic acid-binding lectin (leczyme) induces caspase-dependent apoptosis-mediated mitochondrial perturbation in Jurkat cells
T. Tatsuta (2013)
Valproate, in Combination with Pemetrexed and Cisplatin, Provides Additional Efficacy to the Treatment of Malignant Mesothelioma
F. Vandermeers (2009)
Asbestos causes stimulation of the extracellular signal-regulated kinase 1 mitogen-activated protein kinase cascade after phosphorylation of the epidermal growth factor receptor.
C. Zanella (1996)
Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma
J. Creaney (2014)
Mineral fibre content of lung in mesothelial tumours in North America.
A. Mcdonald (1982)
MicroRNA functions in stress responses.
A. Leung (2010)
Functional analysis of c-Met/hepatocyte growth factor pathway in malignant pleural mesothelioma.
R. Jagadeeswaran (2006)
Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation
H. Yang (2010)
Persistent induction of c-fos and c-jun expression by asbestos.
N. H. Heintz (1993)
Malignant pleural mesothelioma: an epidemiological perspective.
Benjamin M. Robinson (2012)
Iron as a target of chemoprevention for longevity in humans
S. Toyokuni (2011)
New Insight into Intrachromosomal Deletions Induced by Chrysotile in the gpt delta Transgenic Mutation Assay
A. Xu (2007)
The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease
E. Mogilyansky (2013)
Serum mesothelin has a higher diagnostic utility than hyaluronic acid in malignant mesothelioma.
B. Grigoriu (2009)
Fiber counting and analysis in the diagnosis of asbestos-related disease.
A. Churg (1982)
LATS2 is a tumor suppressor gene of malignant mesothelioma.
H. Murakami (2011)
Fiber-induced hydroxyl radical formation: correlation with mesothelioma induction in rats and humans.
K. Maples (1992)
Multipotent Cancer Stem Cells Derived from Human Malignant Peritoneal Mesothelioma Promote Tumorigenesis
S. Varghese (2012)
Vitronectin enhances internalization of crocidolite asbestos by rabbit pleural mesothelial cells via the integrin alpha v beta 5.
A. Boylan (1995)
Mitotic disturbances and micronucleus induction in Syrian hamster embryo fibroblast cells caused by asbestos fibers.
E. Dopp (1995)
Cancer-promoting role of adipocytes in asbestos-induced mesothelial carcinogenesis through dysregulated adipocytokine production.
S. H. Chew (2014)
CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma—A miRNA microarray analysis
Mohamed Guled (2009)
BRCA1 and its toolbox for the maintenance of genome integrity
Michael S. Y. Huen (2010)
Codeletion of p15 and p16 in primary malignant mesothelioma.
S. Xio (1995)
Increased epidermal growth factor-receptor protein in a human mesothelial cell line in response to long asbestos fibers.
J. Pache (1998)
Patterns of inflammation, cell proliferation, and related gene expression in lung after inhalation of chrysotile asbestos.
T. Quinlan (1995)
Early Detection of Malignant Pleural Mesothelioma in Asbestos-Exposed Individuals with a Noninvasive Proteomics-Based Surveillance Tool
R. Ostroff (2012)
MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications.
Sara Busacca (2010)
Genotoxicity and carcinogenicity risk of carbon nanotubes.
S. Toyokuni (2013)
Asbestos modulates thioredoxin-thioredoxin interacting protein interaction to regulate inflammasome activation
Joyce K. Thompson (2014)
Advances in malignant mesothelioma.
B. Robinson (2005)
The effect of iron binding on the ability of crocidolite asbestos to catalyze DNA single-strand breaks.
J. Hardy (1995)
TGF-β synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth
M. Fujii (2012)
BRCA1 and HSP90 cooperate in homologous and non-homologous DNA double-strand-break repair and G2/M checkpoint activation
S. Stecklein (2012)
Distinct affinity of nuclear proteins to the surface of chrysotile and crocidolite
Yurika Kubo (2012)
Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial.
L. Zacharski (2008)
Receptor role of the annexin A2 in the mesothelial endocytosis of crocidolite fibers
K. Yamashita (2015)
Role of oxygen derivatives in the cytotoxicity and DNA damage produced by asbestos on rat pleural mesothelial cells in vitro.
H. Dong (1994)
Multimodality treatment of pleural mesothelioma.
David D. Shersher (2013)
Serum hyaluronate in malignant pleural mesothelioma
T. Frebourg (1987)
Phagocytosis of crocidolite asbestos induces oxidative stress, DNA damage, and apoptosis in mesothelial cells.
W. Liu (2000)
CD146 and insulin‐like growth factor 2 mRNA‐binding protein 3 predict prognosis of asbestos‐induced rat mesothelioma
Y. Okazaki (2013)
Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer.
Y. Sekido (1995)
Genome-Scale Approaches to Investigate Oxidative DNA Damage
S. Akatsuka (2010)
Modulation of genotoxic effects in asbestos-exposed primary human mesothelial cells by radical scavengers, metal chelators and a glutathione precursor.
I. Poser (2004)
Iron and thiols as two major players in carcinogenesis: friends or foes?
S. Toyokuni (2014)
The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma
Matthew J Bott (2011)
Iron overload as a major targetable pathogenesis of asbestos-induced mesothelial carcinogenesis
S. Toyokuni (2014)
Connective tissue growth factor and β‐catenin constitute an autocrine loop for activation in rat sarcomatoid mesothelioma
L. Jiang (2014)
This paper is referenced by
Asbestos Exposure and Lung Carcinogenesis: Mechanism and Applications
P. E. Tokgun (2019)
PROGRESS AND CHALLENGES IN MESOTHELIOMA: FROM BENCH TO BEDSIDE Authors
K. Blyth (2017)
Gene Signature of Malignant Pleural Mesothelioma
A. D. Rienzo (2017)
No cancer predisposition or increased spontaneous mutation frequencies in NEIL DNA glycosylases-deficient mice
V. Rolseth (2017)
Phlebotomy as a preventive measure for crocidolite‐induced mesothelioma in male rats
Y. Ohara (2018)
Mth1 deficiency provides longer survival upon intraperitoneal crocidolite injection in female mice
S. Funahashi (2020)
Non‐thermal plasma induces a stress response in mesothelioma cells resulting in increased endocytosis, lysosome biogenesis and autophagy
L. Shi (2017)
Peroxide dependent effects in human airway epithelial cells exposed to oxidant air pollutants
Phillip A Wages (2016)
Iron addiction with ferroptosis‐resistance in asbestos‐induced mesothelial carcinogenesis: Toward the era of mesothelioma prevention
S. Toyokuni (2019)
Suppressive Effects of Asbestos Exposure on the Human Immune Surveillance System
Y. Nishimura (2017)
Mesothelioma response to carbon nanotubes is associated with an early and selective accumulation of immunosuppressive monocytic cells
F. Huaux (2016)
Connective tissue growth factor produced by cancer-associated fibroblasts correlates with poor prognosis in epithelioid malignant pleural mesothelioma
Y. Ohara (2020)
Chapter 12 Biomarkers of Response to Asbestos Exposure
Induction of Brain Injury and Depression in Rats by Chronic Unpredictable Stress Associated with the Augmentation of Nitrosative Stress and Apoptosis
I. Bin-Jaliah (2020)
Differentially expressed microRNAs in exosomes of patients with breast cancer revealed by next-generation sequencing
H. Wu (2019)
Global overexpression of divalent metal transporter 1 delays crocidolite-induced mesothelial carcinogenesis in male mice
S. Funahashi (2018)
Modulating BAP1 expression affects ROS homeostasis, cell motility and mitochondrial function
Lucie Hébert (2017)
Virtuous cycle of destruction and total recycling of pure asbestos and asbestos-containing waste
G. Talbi (2019)
Genomics and Epigenetics of Malignant Mesothelioma
Adam P Sage (2018)
Biomarkers of Response to Asbestos Exposure
C. Mesaros (2017)
Unmasking the interplay between mTOR and Nox4: novel insights into the mechanism connecting diabetes and cancer
F. Mroueh (2019)
Aberrant expression of FoxP3 in a human T cell line possessing regulatory T cell‑like function and exposed continuously to asbestos fibers.
M. Maeda (2018)
NLRP3 and CARD8 polymorphisms influence risk for asbestos-related diseases.
A. Franko (2020)
Chemopreventive Strategies for Inflammation-Related Carcinogenesis: Current Status and Future Direction
Yusuke Kanda (2017)
Metabolic rewiring and redox alterations in malignant pleural mesothelioma
L. Urso (2019)
The Influence of Genetic Variability in IL1B and MIR146A on the Risk of Pleural Plaques and Malignant Mesothelioma
Petra Piber (2020)
Iron signature in asbestos-induced malignant pleural mesothelioma: A population-based autopsy study
S. Crovella (2016)
Microenvironment and Immunology of the Human Pleural Malignant Mesothelioma
Elisabeth Digifico (2019)
Carbonic anhydrase 9 confers resistance to ferroptosis/apoptosis in malignant mesothelioma under hypoxia
Zili Li (2019)
Fenton reaction‐induced renal carcinogenesis in Mutyh‐deficient mice exhibits less chromosomal aberrations than the rat model
G. H. Li (2017)
Identification of MicroRNAs Involved in Growth Arrest and Apoptosis in Hydrogen Peroxide-Treated Human Hepatocellular Carcinoma Cell Line HepG2
Yuan Luo (2016)
Asbestos and the Pathophysiology of Mesothelioma
N. Zandwijk (2019)See more